These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37592503)

  • 21. The impact of pre-procedural waiting period and anxiety level on pain perception in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Saraçoğlu T; Unsal A; Taşkın F; Sevinçok L; Karaman CZ
    Diagn Interv Radiol; 2012; 18(2):195-9. PubMed ID: 22042731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores.
    Naughton CK; Miller DC; Yan Y
    J Urol; 2001 Jan; 165(1):100-3. PubMed ID: 11125374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
    Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
    J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
    Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC
    J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiety symptoms prior to a prostate cancer diagnosis: Associations with knowledge and openness to treatment.
    Dillard AJ; Scherer LD; Ubel PA; Alexander S; Fagerlin A
    Br J Health Psychol; 2017 Feb; 22(1):151-168. PubMed ID: 27882638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
    Javali TD; Dwivedi DK; Kumar R; Jagannathan NR; Thulkar S; Dinda AK
    Int J Urol; 2014 Mar; 21(3):257-62. PubMed ID: 23980749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
    Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
    Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer.
    Di Franco CA; Jallous H; Porru D; Giliberto GL; Cebrelli T; Tinelli C; Rovereto B
    Arch Ital Urol Androl; 2017 Mar; 89(1):55-59. PubMed ID: 28403597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic effect and psychological impact of an oxidized regenerated cellulose patch after transrectal ultrasound-guided prostate biopsy: A prospective and retrospective study.
    Park JW; Kim JI; Bae SR; Lee YS; Han CH; Kang SH; Park BH
    Medicine (Baltimore); 2019 May; 98(20):e15623. PubMed ID: 31096472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum testosterone levels in African-American and white men undergoing prostate biopsy.
    Kubricht WS; Williams BJ; Whatley T; Pinckard P; Eastham JA
    Urology; 1999 Dec; 54(6):1035-8. PubMed ID: 10604704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of prostate cancer: repeated transrectal prostate biopsy or transurethral resection.
    Lin CC; Huang WJ; Wu LJ; Chang YH; Lin AT; Chen KK
    J Chin Med Assoc; 2008 Sep; 71(9):448-54. PubMed ID: 18818137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer detection yield in repeated biopsy is independent of the diagnosis of earlier biopsies.
    Grepl M; Student V; Furst T; Furstova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):297-302. PubMed ID: 20208971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
    Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
    Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
    Avery KN; Metcalfe C; Blazeby JM; Lane JA; Neal DE; Hamdy FC; Donovan JL
    BJU Int; 2008 Dec; 102(11):1629-33. PubMed ID: 18710456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.